Maine Center for Cancer Medicine-Scarborough

Scarborough, Maine 04074

Use our guide to learn which trials are right for you!

We've found
13 trials
at this facility
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling, Phase II, III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
Status: Enrolling, Phase I
Updated: 3/21/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 3/24/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Status: Enrolling, Phase II
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Clinical Trial
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling, Phase I, II
Updated: 4/4/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Status: Enrolling, Phase III
Updated: 4/5/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials